21 CFR 520.2123a

§ 520.2123a Spectinomycin tablets.

United States · 21 CFR — Food and Drugs · Status: effective

Cite this

Citation: 21 CFR 520.2123a, § 520.2123a Spectinomycin tablets, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87307
Permanent ID: ys:prov:87307@1
SHA-256: 285a3772c1a478dcd8ddb38e4993a81d0b21b562d8debaa6f7471ca959098f05

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) Specifications. Each tablet contains spectinomycin dihydrochloride equivalent to 100 milligrams (mg) spectinomycin. (b) Sponsors. See Nos. 054771 and 061133 in § 510.600(c) of this chapter. (c) Conditions of use in dogs—(1) Amount. Administer orally to provide 10 mg per pound (lb) of body weight twice daily. Dosage may be continued for 4 consecutive days. (2) Indications for use. For the treatment of infectious diarrhea and gastroenteritis caused by organisms susceptible to spectinomycin. (3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.